Board restructuring: Gail Schoettler becomes non-executive Chair, Daryl Faulkner steps down as Executive Chairman
Company: Riot
What the later record shows
Not a promise: a reported event · happened October 7, 2010
The claim, made on 2010-10-21, reports board changes that took effect on October 7, 2010, which had already happened.
Checked October 10, 2026 against filings, releases and reporting published after the claim was made. Quotes are verbatim from the linked documents.
The claim, verbatim
Effective October 7, 2010, Gail Schoettler became non-executive Chair of the Board of Directors, Daryl Faulkner stepped down from the position of Executive Chairman, and the office of Vice Chairman was eliminated.
Source (primary)
Riot DEF 14A filed 2010-10-22 (SEC EDGAR, sec_filing)
View cached copy (2026-09-27)Live source ↗
Quote: “Effective as of October 7, 2010, Gail Schoettler became Chair of the Board of Directors of the Company, Daryl Faulkner stepped down from the officer role of Executive Chairman and the office of Vice Chairman was eliminated.”
How we checked this
Checked on October 12, 2026. The cited source supports every part of this claim.
The proxy statement describes all three October 7, 2010 governance changes and calls Schoettler's position non-executive Chair of the Board.
Confirmed in the source:
- Effective October 7, 2010, Gail Schoettler became Chair of AspenBio Pharma's Board of Directors
- Schoettler's role as Chair was non-executive
- Effective October 7, 2010, Daryl Faulkner stepped down from the officer role of Executive Chairman
- Effective October 7, 2010, the office of Vice Chairman was eliminated
What we did: Read our cached copy of SEC EDGAR (https://www.sec.gov/Archives/edgar/data/1167419/000107997310001118/appy_def14a.htm) in full (159,763 characters, retrieved September 27, 2026) and checked each assertion in the claim against it.
Additional evidence
confirms Riot DEF 14A filed 2010-10-22
Quote: “Effective as of October 7, 2010, Gail Schoettler became Chair of the Board of Directors of the Company, Daryl Faulkner stepped down from the officer role of Executive Chairman and the office of Vice Chairman was eliminated.”